(HealthDay)—Overall survival among older adults with diffuse large B-cell lymphoma (DLBCL) has improved over time, but five-year survival is less than 40 percent, according to a study published online June 12 in Leukemia & Lymphoma. Jaime Shaw, from Amgen Inc. in Thousand Oaks, California, and colleagues describe temporal trends in treatment among patients ≥66 years […]